Trials / Completed
CompletedNCT04227860
Balance and Strength Exercise in Knee Osteoarthritis Patients
The Effect of Combined Balance and Strength Exercise Program in Patients With Different Grades of Primary Knee Osteoarthritis Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- University of Alexandria · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to assess the effect of balance exercise on dynamic balance and physical function in 80 patients with different grades of primary knee osteoarthritis (KOA).
Detailed description
The study will include 80 patients with primary knee osteoarthritis divided into 4 groups according to the Kellgren and Lawrence grading scale (KL): Group 1: 20 patients with grade I KOA Group 2: 20 patients with grade II KOA Group 3: 20 patients with grade III KOA Group 4: 20 patients with grade IV KOA * Patients will undergo pre-exercise and post- exercise assessment with: 1. Western Ontario and McMaster University Osteoarthritis Index (WOMAC) 2. Modified Stare Excursion Balance test 3. Timed up and Go test * Exercise program includes: 1. Lower extremity kinesthesia and balance exercise program 2. Strength exercise program
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Balance exercise program | Patients will be engaged in lower extremity kinesthesia and balance exercise program 3 time per week for 6 weeks. Divided into 2 stages, stage 1 and 2, each stage 3 weeks. Patients who fulfill at least stage 1 of the program will be included in the study. |
| OTHER | Strengthening exercise program | Patients will be engaged in strengthening exercise program 3 time per week for 6 weeks. Divided into 3 stages, stage 1, 2 and 3, each stage 2 weeks. Patients who fulfill at least stage 1 of the program will be included in the study. |
Timeline
- Start date
- 2020-01-20
- Primary completion
- 2021-06-01
- Completion
- 2021-12-31
- First posted
- 2020-01-14
- Last updated
- 2022-05-26
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04227860. Inclusion in this directory is not an endorsement.